Is there any relationship between actual benefit and added value of drugs and pharmacovigilance alerts?: Letter to the Editors

British Journal of Clinical Pharmacology

Volumn 68, Issue 1, 2009, Pages 124-125

  Tavassoli, Neda ^a   Montastruc, Jean Louis ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

DRUG APPROVAL; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FRANCE; HUMAN; LETTER; PRIORITY JOURNAL; REIMBURSEMENT; UNSPECIFIED SIDE EFFECT;

DRUG THERAPY; ECONOMICS, PHARMACEUTICAL; FRANCE; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 67650966716     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03403.x     Document Type: Letter

References (2)

1. Home page of 'haute Autorité de santé Available at http://www.has-sante.fr/portail/jcms/c-5443/english?cid=c-5443 (last accessed 4th February 2009).
2. Centre National Hospitalier d'Information sur le Médicament (CNHIM). Available at http://www.theriaque.org/InfoMedicaments/home.cfm?menu- info-medicaments=choixRMO (last accessed 5 February 2009).